Pitcairn’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Sell |
18,795
-6,319
| -25% | -$442K | 0.09% | 215 |
|
|
2025
Q1 | $1.85M | Buy |
25,114
+4,818
| +24% | +$354K | 0.11% | 166 |
|
|
2024
Q4 | $1.33M | Sell |
20,296
-3,479
| -15% | -$228K | 0.08% | 218 |
|
|
2024
Q3 | $1.85M | Sell |
23,775
-840
| -3% | -$65.4K | 0.11% | 172 |
|
|
2024
Q2 | $1.92M | Buy |
24,615
+3,808
| +18% | +$297K | 0.12% | 161 |
|
|
2024
Q1 | $1.41M | Buy |
20,807
+8,184
| +65% | +$554K | 0.09% | 209 |
|
|
2023
Q4 | $850K | Buy |
12,623
+4,846
| +62% | +$326K | 0.06% | 272 |
|
|
2023
Q3 | $527K | Buy |
7,777
+1,504
| +24% | +$102K | 0.04% | 344 |
|
|
2023
Q2 | $449K | Buy |
6,273
+35
| +0.6% | +$2.51K | 0.04% | 387 |
|
|
2023
Q1 | $433K | Buy |
6,238
+1,556
| +33% | +$108K | 0.04% | 382 |
|
|
2022
Q4 | $317K | Sell |
4,682
-329
| -7% | -$22.3K | 0.03% | 447 |
|
|
2022
Q3 | $275K | Buy |
5,011
+1,278
| +34% | +$70.1K | 0.03% | 456 |
|
|
2022
Q2 | $247K | Buy |
+3,733
| New | +$247K | 0.03% | 498 |
|
|
2013
Q4 | – | Sell |
-10,218
| Closed | -$265K | – | 472 |
|
|
2013
Q3 | $265K | Sell |
10,218
-3,840
| -27% | -$99.6K | 0.03% | 386 |
|
|
2013
Q2 | $333K | Buy |
+14,058
| New | +$333K | 0.04% | 326 |
|